Published in TB and Outbreaks Week, March 13th, 2012
"For this study, Ab responses to AM and glucan for 47 U. S. TB patients (33 HIV negative [HIV-], 14 HIV positive [HIV+]), 42 healthy controls, and 38 asymptomatic HIV+ controls were evaluated by enzyme-linked immunosorbent assays (ELISAs). The results were compared with Ab responses to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.